Table 1. .
Patient Characteristics and Virological Features at Presentation of Dengue Fever
| Anti-HCV(+) | |||||||
|---|---|---|---|---|---|---|---|
| Overall | Anti-HCV(-) | Anti-HCV(+) | HCV RNA(+) | HCV RNA(-) | |||
| n = 515 | n = 483 | n = 32 | P | n = 12 | n = 20 | P | |
| Male | 274 (53.2) | 258 (53.4) | 16 (50.0) | .708 | 5 (41.7) | 11 (55.0) | .465 |
| Age, y | 56.9 ± 15.8 | 56.6 ± 16.0 | 61.8 ± 11.3 | .018* | 61.1 ± 12.8 | 62.5 ± 10.5 | .641 |
| HCV RNA, log IU/mL | 3.51 ± 1.15 | ||||||
| HCV genotype 1b/2/UD | 7/4/1 | ||||||
| HCV tx-experienced | 10 (31.3) | 1 (8.30) | 9 (45.0) | <.05* | |||
| Anti-HCV titer, s/co | 10.4 ± 5.93 | 14.7 ± 3.86 | 7.75 ± 5.47 | <.001* | |||
| HBsAg (+) | 95 (18.4) | 88 (18.2) | 7 (21.9) | .606 | 1 (8.30) | 6 (30.0) | .212 |
| Liver cirrhosis | 3 (9.38) | 1 (7.14) | 2 (11.1) | 1.000 | |||
| The year of DF, 2014/2015 | 195/320 | 182/301 | 13/19 | .740 | 6/6 | 7/13 | .473 |
| Laboratory data during DF | |||||||
| AST, IU/L | 242 ± 1136 | 252 ± 1174 | 100 ± 81.6 | .468 | 138 ± 114 | 78.6 ± 44.4 | .102 |
| ALT, IU/L | 133 ± 282 | 137 ± 290 | 76.8 ± 94.7 | .240 | 68.8 ± 37.8 | 81.5 ± 117 | .723 |
| Bil(T), mg/dL | 0.97 ± 0.59 | 0.96 ± 0.61 | 1.03 ± 0.22 | .738 | 1.04 ± 0.23 | 1.02 ± 0.24 | .451 |
| Cr, mg/dL | 1.17 ± 1.24 | 1.18 ± 1.27 | 1.04 ± 0.62 | .561 | 1.18 ± 0.99 | 0.97 ± 0.29 | .930 |
| WBC, 1000/μL | 2.90 ± 1.28 | 2.89 ± 1.27 | 3.14 ± 1.43 | .283 | 3.01 ± 1.35 | 3.21 ± 1.50 | .706 |
| Hb, g/dL | 12.7 ± 2.00 | 12.7 ± 2.00 | 12.8 ± 2.02 | .823 | 12.3 ± 1.84 | 13.1 ± 2.02 | .164 |
| Plt, 1000/μL | 70.4 ± 53.1 | 70.3 ± 53.3 | 70.9 ± 50.0 | .954 | 68.9 ± 46.7 | 72.1 ± 52.8 | .858 |
| Prognosis of DF | |||||||
| Dengue hemorrhagic fever | 106 (20.6) | 97 (20.1) | 9 (28.1) | .276 | 3 (25.0) | 6 (30.0) | 1.000 |
| Severe dengue | 34 (6.60) | 32 (6.60) | 2 (6.30) | 1.000 | 1 (8.30) | 1 (5.00) | 1.000 |
Data are presented as No. (%) or mean ± SD. HCV RNA levels are presented as logarithmic values (base number 10).
Abbreviations: ALT, alanine aminotransferase; anti-HCV, antibody to HCV; AST, aspartate aminotransferase; Bil, total bilirubin; Cr, creatinine; DF, dengue fever; Hb, hemoglobin; HBsAg, hepatitis B virus surface antigen; HCV, hepatitis C virus; Plt, platelet; tx, treatment; UD, undetermined; WBC, white blood cells.
*P < .05.